Parenteral fluid therapy

145
PARENTERAL FLUID THERAPY Maria Carmela L. Domocmat, RN, MSN Assistant Professor School of Nursing Northern Luzon Adventist College

description

Intravenous Therapy

Transcript of Parenteral fluid therapy

Page 1: Parenteral fluid therapy

PARENTERAL FLUID

THERAPY Maria Carmela L. Domocmat, RN, MSN

Assistant Professor

School of Nursing

Northern Luzon Adventist College

Page 2: Parenteral fluid therapy

Outline • Definition of IV therapy

• Indication of IV therapy

• Type of IV solution

• Nursing role in managing patient receiving IV therapy

Page 3: Parenteral fluid therapy

DEFINITION OF IV

THERAPY

Page 4: Parenteral fluid therapy

Definition of IV therapy It is an effective and efficient method of supplying fluid

directly into intravenous fluid compartment producing

rapid effect with availability of injecting large volume

of fluid more than other method of administration.

Page 5: Parenteral fluid therapy

INDICATION OF IV THERAPY

Page 6: Parenteral fluid therapy

PURPOSE

• The choice of an IV solution depends on the purpose of

its administration.

• Restore or maintain F & E

• Administer meds

• Provide nutrition

• Transfusion

• Route for blood samples

Page 7: Parenteral fluid therapy

TYPE OF IV SOLUTION

Page 8: Parenteral fluid therapy

Types of Solutions

• Isotonic

• Expand intravascular volume

• 0.9% Saline

• D5W

• Lactated ringers

Page 9: Parenteral fluid therapy

Types of Solutions

• Hypertonic

• Draw fluid from cells

• D5 in 0.45 Saline

• D5 in NS

• D5 LR

• 3% NaCl

• D10W

• Hypotonic

• Shift fluid into cells

• 0.33% Saline

• 0.45% Saline

• 2.5 Dextrose

Page 10: Parenteral fluid therapy

EQUIPMENT OF I.V. THERAPY

Page 11: Parenteral fluid therapy

Equipment

• Containers

• Glass bottles

• Plastic bags

• Administration Sets • IV set

• Macro drips

• Microdrips

• Y ports

• Buretrols

• In line filters

• Timing strips

• Electronic Infusion Devices

Page 12: Parenteral fluid therapy

IV Infusion Method

IV Infusion Method

I.V. Bolus (I.V. push)

Continuous-drip infusion

Intermittent infusion

Page 13: Parenteral fluid therapy

Equipment of I.V. therapy

Solution containers

administration sets

Page 14: Parenteral fluid therapy
Page 15: Parenteral fluid therapy
Page 16: Parenteral fluid therapy

VENIPUNCTURE DEVICES

• Equipment used to gain access to the vasculature

includes

• Cannulas

• needleless IV delivery systems

• peripherally inserted central catheter or midline catheter access

lines.

Page 17: Parenteral fluid therapy

Venipuncture Devices: CANNULAS

• Most common peripheral access devices

• have an obturator inside a tube that is later removed.

“Catheter” and “cannula” : used interchangeably.

• main types of cannula devices available are those

referred to

• winged infusion sets (butterfly) with a steel needle or as over-the-

needle catheter with wings

• indwelling plastic cannulas inserted over a steel needle

• indwelling plastic cannulas inserted through a steel needle.

Page 18: Parenteral fluid therapy

• Scalp vein or butterfly needles

• short steel needles with plastic wing handles

• Easy to insert

• but infiltration occurs easily

• because they are small and nonpliable,

• use should be limited to obtaining blood specimens or

administering bolus injections or infusions lasting only a few hours

• increase the risk for vein injury and infiltration.

Page 19: Parenteral fluid therapy

• over-the-needle catheter

• less likely to cause infiltration

• available in long lengths

• well suited for placement in central locations.

• Parts:

• Intracatheters: Plastic cannulas inserted through a hollow needle

• Stylet

Page 20: Parenteral fluid therapy
Page 21: Parenteral fluid therapy
Page 22: Parenteral fluid therapy
Page 23: Parenteral fluid therapy
Page 24: Parenteral fluid therapy

Venipuncture Devices: NEEDLELESS IV

DELIVERY SYSTEMS • an effort to decrease needlestick injuries and exposure to

HIV, hepatitis, and other bloodborne pathogens

Page 25: Parenteral fluid therapy

Blunt cannula syringe

Page 26: Parenteral fluid therapy
Page 27: Parenteral fluid therapy
Page 28: Parenteral fluid therapy

Venipuncture Devices: Peripherally Inserted Central

Catheter or Midline Catheter Access Lines

• Patients who need moderate- to long-term parenteral

therapy

• For patients with limited peripheral access

• obese or emaciated patients, IV/injection drug users

• require IV antibiotics, blood, and parenteral nutrition.

• Requires median cephalic, basilic, and cephalic veins

• pliable (not sclerosed or hardened)

• not subject to repeated puncture.

• If these veins are damaged

• central venous access via the subclavian or internal jugular vein

• surgical placement of an implanted port or a vascular access

device

Page 29: Parenteral fluid therapy

NURSING MANAGEMENT OF

THE PATIENT RECEIVING IV

THERAPY

Page 30: Parenteral fluid therapy

Components of IV Orders

• Type of Solution

• Additives

• Rate and volume

• Duration

• Method

Page 31: Parenteral fluid therapy

ASSESSMENT

Page 32: Parenteral fluid therapy

Nursing assessment 1- assess the solution:

2- Reading the label on the solution.

3- Determine the compatibility of all fluid and additives.

No leakage Sterile No small particles

Clear and not

expired

Page 33: Parenteral fluid therapy

Nursing assessment

4- observe I.V sets

Cracks Holes Missing clamps

Expired date

Page 34: Parenteral fluid therapy

• Also assess the patient for :

1- Any allergies and arm placement preference.

2- Any planned surgeries.

3- Patient’s activities of daily living.

4- Type and duration of I.V therapy, amount, and rate.

Page 35: Parenteral fluid therapy

PREPARING TO ADMINISTER IV

THERAPY • Before performing venipuncture

• hand hygiene

• applies gloves

• informs patient about procedure

• Select most appropriate insertion site and type of cannula

for a particular patient.

Page 36: Parenteral fluid therapy
Page 37: Parenteral fluid therapy

Factors influencing choices of insertion

site • type of solution to be administered

• expected duration of IV therapy

• patient’s general condition

• availability of veins

• skill of the person initiating the infusion

Page 38: Parenteral fluid therapy

CHOOSING AN IV SITE

• Many sites can be used for IV therapy, but ease of access

and potential hazards vary.

• peripheral locations

• ordinarily only sites used by nurses

• arm veins are most commonly used – coz safe and easy to enter

• arm veins

• metacarpal, cephalic, basilic, and median veins

• More distal sites should be used first, with more proximal

sites used subsequently.

Page 39: Parenteral fluid therapy

CHOOSING AN IV SITE

• Avoid the following

• Leg veins because of high risk of thromboembolism.

• veins distal to a previous IV infiltration or phlebitic area, sclerosed

or thrombosed veins,

• arm with arteriovenous shunt or fistula

• arm affected by edema, infection, blood clot, or skin breakdown.

• arm on side of mastectomy because of impaired lymphatic flow.

Page 40: Parenteral fluid therapy

• Central veins

• commonly used by physicians

• subclavian and internal jugular veins.

• Can gain access to (or cannulate) even when peripheral sites have

collapsed

• allow for administration of hyperosmolar solutions.

• Hazards are much greater

Page 41: Parenteral fluid therapy

• Consider mobility

• Inspect both arms and hands and choose the site that does not

interfere with mobility.

• antecubital fossa is avoided : except as a last resort.

• Take note from far to near

• most distal site of the arm or hand is generally used first so that

subsequent IV access sites can be moved progressively upward.

Page 42: Parenteral fluid therapy

factors to consider when selecting a site

for venipuncture: • Condition of the vein

• Type of fluid or medication to be infused

• Duration of therapy

• Patient’s age and size

• Whether the patient is right- or left-handed

• Patient’s medical history and current health status

• Skill of the person performing the venipuncture

Page 43: Parenteral fluid therapy

• After applying a tourniquet, the nurse palpates and

inspects the vein.

• The vein should feel firm, elastic, engorged, and round,

not hard, flat, or bumpy.

• Because arteries lie close to veins in the antecubital

fossa, the vessel should be palpated for arterial pulsation

(even with a tourniquet on), and cannulation of pulsating

vessels should be avoided.

Page 44: Parenteral fluid therapy

General guidelines for selecting a cannula

include: • Length: 3⁄4 to 1.25 inches long

• Diameter: narrow diameter of the cannula to occupy minimal

space within the vein

• Gauge:

• 20 to 22 gauge for most IV fluids; a larger gauge for caustic or viscous

solutions

• 14 to 18 gauge for blood administration and for trauma patients and

those undergoing surgery

• 22 to 24gauge for elderly

Note: Hand veins are easiest to cannulate.

Cannula tips should not rest in a flexion area (eg, the antecubital

fossa) as this could inhibit the IV flow.

Page 45: Parenteral fluid therapy

PREPARING THE IV SITE

• Before preparing the skin, ask patient allergy to latex or

iodine

• Excessive hair at selected site may be removed by

clipping

• to increase the visibility of the veins and

• to facilitate insertion of the cannula and adherence of dressings to

the IV insertion site.

Page 46: Parenteral fluid therapy

Sites

• Peripheral

• arms

• legs

• Central

• subclavian

• internal jugular

• uses

Page 47: Parenteral fluid therapy

Figure 48.13b

Page 48: Parenteral fluid therapy

Figure 48.13a

Page 49: Parenteral fluid therapy

?

?

Page 50: Parenteral fluid therapy

Figure 48.14

Page 51: Parenteral fluid therapy

Figure 48.14b

Page 52: Parenteral fluid therapy

NURSING DIAGNOSIS

Page 53: Parenteral fluid therapy

Nursing diagnosis:

• Anxiety (mild, moderate, severe) related to threat

regarding therapy.

• Fluid volume excess.

• Fluid volume deficit.

• Risk for infection.

• Risk for sleep pattern disturbance.

• Knowledge deficit related to

I.V therapy.

Page 54: Parenteral fluid therapy

PLANNING

Page 55: Parenteral fluid therapy

Planning

• Identify expected outcomes which focus on:

• preventing complications from I.V therapy.

• minimal discomfort to the patient.

• restoration of normal fluid and electrolyte balance .

• patient’s ability to verbalize complications.

Page 56: Parenteral fluid therapy

IMPLEMENTATION

Page 57: Parenteral fluid therapy

Implementation during initiation phase

• Solution preparation

• Label the I.V container.

• Avoid the use of felt-tip pens or permanent markers on plastic

bag.

• Hang I.V bag or bottle

Page 58: Parenteral fluid therapy

• Site preparation

1. Cleanse infusion site

• The insertion site is scrubbed with a sterile pad soaked in 10%

povidone–iodine (Betadine) or chlorhexidine gluconate solution for 2 to

3 minutes

• from the center of the area to the periphery

• Allow the area to air day.

• site should not be wiped with 70% alcohol • because the alcohol negates the effect of the disinfecting solution

• Alcohol pledgets are used for 30 seconds instead, only if the patient is allergic

to iodine

2. Excessive hair at selected site should be clipped with scissor .

Page 59: Parenteral fluid therapy

• Maintain sterility of equipment

• IV device, the fluid, the container, and tubing must be sterile

• Because infection can be a major complication of IV therapy

• perform hand hygiene

• put on gloves: nonsterile disposable gloves

Page 60: Parenteral fluid therapy

PERFORMING VENIPUNCTURE

• Venipuncture: the ability to gain access to the venous

system for administering fluids and medications

Page 61: Parenteral fluid therapy
Page 62: Parenteral fluid therapy
Page 63: Parenteral fluid therapy
Page 64: Parenteral fluid therapy
Page 65: Parenteral fluid therapy

Source: Brunner and Suddhart, 2010)

Page 66: Parenteral fluid therapy
Page 67: Parenteral fluid therapy
Page 68: Parenteral fluid therapy
Page 69: Parenteral fluid therapy

Implementation during maintenance

phase • inspect the tubing.

• inspect the I.V set at routine intervals at least daily.

• Monitor vital signs .

• recount the flow rate after 5 and 15 minutes after

initiation

• Site care

• Dressings

• Tubing and bag changes

• Prevent complications

Page 70: Parenteral fluid therapy

• Intermittent flushing of I.V lines

• Peripheral intermittent are usually flushed with saline (2-3 ml

0.9% NS.)

• Replacing equipments (I.V container, I.V set, I.V

dressing):

• I.V container should be changed when it is empty.

• I.V set should be changed every 24 hours.

• The site should be inspected and palpated for tenderness every

shift or daily/cannula should be changed every 72hours and if

needs.

• I.V dressing should be changed daily and when needed

Page 71: Parenteral fluid therapy

• Regulating flow rate

gtt/min min/1h) (60 minutesin time

set) gtt/ml(IV(ml/h) infused be tovolume

Page 72: Parenteral fluid therapy

MONITORING THERAPY

• Maintaining an existing IV infusion is a nursing

responsibility that demands knowledge of the solutions

being administered and the principles of flow.

• patients must be assessed carefully for both local and

systemic complications.

Page 73: Parenteral fluid therapy

Monitoring Therapy

• Flow Rate

• Influences

• Height of container

• Diameter of tubing/cannula

• Length of tubing

• Viscosity

• Cannula position

• Position of extremity

• Site care

• dressings

• site change

• Tubing and bag changes

• Prevent complications

Page 74: Parenteral fluid therapy

FACTORS AFFECTING FLOW

• Height of container

• Flow is directly proportional to the height of the liquid column.

• Raising the height of the infusion container may improve sluggish

flow.

• Diameter of tubing and cannula

• Flow is directly proportional to the diameter of the tubing.

• The clamp on IV tubing regulates the flow by changing the tubing

diameter.

• flow is faster through large-gauge rather than small- gauge

cannulas.

Page 75: Parenteral fluid therapy

FACTORS AFFECTING FLOW

• Length of tubing

• Flow is inversely proportional to the length of the tubing.

• Adding extension tubing to an IV line will decrease the flow.

• Viscosity

• Flow is inversely proportional to the viscosity of a fluid.

• viscous IV solutions (ex: blood) require a larger cannula than water

or saline solutions

• Cannula position

• Position of extremity

Page 76: Parenteral fluid therapy

IV infusion pumps

Page 77: Parenteral fluid therapy

EVALUATION

Page 78: Parenteral fluid therapy

Evaluation

• Produce therapeutic response to medication, fluid and

electrolyte balance.

• Observe functioning and patency of I.V system.

• Absence of complications.

Page 79: Parenteral fluid therapy
Page 80: Parenteral fluid therapy

DISCONTINUING AN INFUSION

• The nurse never use scissors to remove the tape or

dressing.

• Apply pressure to the site for 2 to 3 minutes using a dry,

sterile gauze pad.

• Inspect the catheter for intactness.

• The arm or hand may be flexed

• or extended several times.

Page 81: Parenteral fluid therapy

DISCONTINUING AN INFUSION

• The removal of an IV catheter is associated with two

possible dangers:

• bleeding

• catheter embolism

• To prevent excessive bleeding

• dry, sterile pressure dressing should be held over the site as the

catheter is removed.

• Firm pressure is applied until hemostasis occurs.

Page 82: Parenteral fluid therapy

• Catheter embolism

• Preventive measures

• Avoid using scissors near the catheter.

• Avoid withdrawing the catheter through the insertion needle.

• Follow the manufacturer’s guidelines carefully (eg, cover the needle

point with the bevel shield to prevent severance of the catheter).

• Management

• If the catheter clearly has been severed, the nurse can attempt to

occlude the vein above the site by applying a tourniquet to prevent the

catheter from entering the central circulation (until surgical removal is

possible). As always, however, it is better to prevent a potentially fatal

problem than to deal with it after it has occurred

Page 83: Parenteral fluid therapy

DOCUMENTATION

Page 84: Parenteral fluid therapy

Recording and reporting:

• Type of fluid, amount, flow rate, and any drug added.

• Insertion site.

• Size and type of I.V catheter or needle.

• The use of pump.

• When infusion was begun and discontinuing.

• Expected time to change I.V bag or bottle, tubing,

cannula, and dressing.

Page 85: Parenteral fluid therapy

• Any side effect.

• Type and amount of flush solution.

• Intake and output every shift, daily weight.

• Temperature every 4 hours.

• Blood glucose monitoring every 6 hours, and rate of

infusion.

Page 86: Parenteral fluid therapy

Documentation

• Starting the IV

• 10/3/08 – 0900 hours – #22 1-inch Gelco inserted on first attempt to

R cephalic vein, NS infusing via pump at 125cc/hr. Pt tolerated

procedure well. S. Wise, RNC

• Discontinuing the IV

• 10/3/08 – 2000 hours – IV R wrist removed without difficulty, cathlon

intact. Pt tolerated well. S. Wise, RNC

Page 87: Parenteral fluid therapy

COMPLICATIONS

Page 88: Parenteral fluid therapy

Complications

Local

• Hematoma

• Thrombosis

• Thrombophlebitis

• Phlebitis

• Infiltration

• Extravasation

• Infection

Page 89: Parenteral fluid therapy

Local Complication

Infiltration Extravasation

Page 90: Parenteral fluid therapy

Infiltration and Extravasation

• Infiltration : unintentional administration of a nonvesicant

solution or medication into surrounding tissue.

• occur when IV cannula dislodges or perforates the wall of

the vein.

Page 91: Parenteral fluid therapy

Infiltration: S/S

• edema around insertion site

• leakage of IV fluid from insertion site

• discomfort and coolness in area of infiltration

• significant decrease in the flow rate

• When solution is particularly irritating, sloughing of tissue

may result.

Page 92: Parenteral fluid therapy

• Closely monitoring the insertion site is necessary to detect

infiltration before it becomes severe.

• How to check?

• insertion area is larger than same site of the opposite extremity

• Backflow of blood into tubing proves that the catheter is properly

placed within the vein. True or false?

• If the catheter tip has pierced the wall of the vessel, however, IV fluid

will seep into tissues as well as flow into the vein.

• Although blood return occurs, infiltration has occurred as well.

Page 93: Parenteral fluid therapy

• Closely monitoring the insertion site is necessary to detect

infiltration before it becomes severe.

• How to check?

• apply a tourniquet above (or proximal to) infusion site and

tighten it enough to restrict venous flow.

• If the infusion continues to drip despite the venous obstruction,

infiltration is present.

Page 94: Parenteral fluid therapy

Management

• infusion should be stopped

• IV discontinued

• a sterile dressing applied to the site after careful

inspection to determine the extent of infiltration.

• infiltration of any amount of blood product, irritant, or vesicant is

considered the most severe.

• Start another IV infusion at new site or proximal to

infiltration if same extremity is used.

Page 95: Parenteral fluid therapy

Management

• warm compress to the site

• if small volumes of noncaustic solutions have infiltrated over a long

time

• cold compress

• ithe infiltration is recent

• Elevate affected extremity to promote the absorption of

fluid

• Use standardized infiltration scale to document the

infiltration (Infusion Nursing Standards of Practice)

Page 96: Parenteral fluid therapy

Standardized infiltration scale

0 = No symptoms

1 = Skin blanched, edema less than 1 inch in any direction,

cool to touch, with or without pain

2 = Skin blanched, edema 1 to 6 inches in any direction, cool

to touch, with or without pain

3 = Skin blanched, translucent, gross edema greater than

6 inches in any direction, cool to touch, mild to moderate

pain, possible numbness

4 = Skin blanched, translucent, skin tight, leaking, skin discolored, bruised, swollen, gross edema greater than 6 inches in any direction, deep pitting tissue edema, circulatory

impairment, moderate to severe pain, infiltration of any

amount of blood products, irritant, or vesicant

Page 97: Parenteral fluid therapy

Prevention

• Inspect site every hour for

• Redness

• Pain

• Edema

• blood return

• coolness at the site

• IV fluid draining from the IV site.

• Use appropriate size and type of cannula for vein

prevents this complication

Page 98: Parenteral fluid therapy

Very Serious Complications Can Occur

• Infiltration

• Non vesicant solution

• Extravasation

• Vesicant solution

Page 99: Parenteral fluid therapy

Extravasation

• similar to infiltration with an inadvertent administration of

vesicant or irritant solution or medication into the

surrounding tissue.

• Medications such as dopamine

• calcium preparations

• chemotherapeutic agents

• can cause pain, burning, and redness at the site

• Blistering, inflammation, and necrosis of tissues can

occur.

Page 100: Parenteral fluid therapy

Vesicant Medications/Solutions

• Fluoroquinolones • Cipro, levaquin, floxin

• Gentamicin

• Nafcillin

• Penicillin

• Vancomycin

• Calcium chloride

• Calcium gluconate

• Potassium chloride

• Sodium bicarbonate

• Cytotoxic agents

• Valium

• Dextrose

• Dobutrex

• Dopamine

• Fat emulsion

• TPN

• Dilantin

• Phenergan

• Diprovan

• Radiographic contrast agents

Page 101: Parenteral fluid therapy

• The extent of tissue damage is determined by

• concentration of medication

• quantity that extravasated

• location of the infusion site

• tissue response

• duration of process of extravasation

Page 102: Parenteral fluid therapy

Management

• Stop infusion

• Notify physician promptly.

• Initiate agency’s protocol for extravasation • protocol may specify specific treatments, including

• Antidotes specific to the medication that extravasated

• IV line should remain in place or be removed before treatment.

• infusion site be infiltrated with an antidote prescribed after assessment by the physician and application of warm or cold compresses, depending on the medication infusing.

• extremity should not be used for further cannula placement.

• Thorough neurovascular assessments of the affected extremity must be performed frequently

Page 103: Parenteral fluid therapy

Prevention

• Review institution’s IV policy and procedures and

incompatibility charts and checking with the pharmacist

before administering any IV medication, whether given

peripherally or centrally

• to determine incompatibilities and vesicant potential.

• Careful, frequent monitoring of the IV site

• avoid insertion of IV devices in areas of flexion

Page 104: Parenteral fluid therapy

Prevention

• secure the IV line

• use smallest catheter possible that accommodates the

vein

• when vesicant medication is administered by IV push, it

should be given through a side port of an infusing IV

solution to dilute the medication and decrease severity of

tissue damage if extravasation occurs

Page 105: Parenteral fluid therapy
Page 106: Parenteral fluid therapy

Phlebitis

• inflammation of a vein related to a chemical or mechanical

irritation, or both.

Page 107: Parenteral fluid therapy

S/S

• reddened, warm area around the insertion site or along

the path of the vein

• pain or tenderness at the site or along the vein, and

swelling.

• incidence of phlebitis increases with

• Length of time the IV line is in place

• composition of the fluid or medication infused (especially its pH and

tonicity)

• size and site of the cannula inserted

• ineffective filtration

• improper anchoring of the line

• introduction of microorganisms at the time of insertion.

Page 108: Parenteral fluid therapy

specific standards for assessing phlebitis

• Intravenous Nursing Society

Page 109: Parenteral fluid therapy

Thrombophlebitis

• refers to presence of a clot plus inflammation in the vein.

Page 110: Parenteral fluid therapy

Thrombophlebitis- S/S

• Localized pain

• redness, warmth, and swelling around the insertion site or

along the path of the vein

• immobility of the extremity because of discomfort

• swelling, sluggish flow rate

• Fever

• Malaise

• Leukocytosis

Page 111: Parenteral fluid therapy

Management

• D/C IV infusion

• 1st: cold compress to decrease the flow of blood and

increase platelet aggregation

• followed by a warm compress

• Elevate extremity

• Restart line in the opposite extremity

• If (+) patient has signs and symptoms of thrombophlebitis,

the IV line should not be flushed

• (although flushing may be indicated in the absence of phlebitis to

ensure cannula patency and to prevent mixing incompatible

medications and solutions).

Page 112: Parenteral fluid therapy

Prevention

• Avoid trauma to vein at time the IV is inserted,

• Observe site every hour

• Check medication additives for compatibility

Page 113: Parenteral fluid therapy

Local Complication- Hematoma

• Hematoma • S & S

• Interventions

• Prevention

Page 114: Parenteral fluid therapy

Hematoma

• Hematoma results when blood leaks into tissues

surrounding the IV insertion site.

• Leakage can result from

• perforation of opposite vein wall during venipuncture

• Needle slipping out of vein

• insufficient pressure applied to the site after removing the needle or

cannula.

Page 115: Parenteral fluid therapy

s/s

• Ecchymosis

• immediate swelling at site

• leakage of blood at site.

Page 116: Parenteral fluid therapy

Management

• Remove needle or cannula and apply pressure with a

sterile dressing

• Apply ice for 24 hours to

• site to avoid extension of the hematoma

• then warm compress to increase absorption of blood;

• assessing the site

• Restart the line in the other extremity if indicated.

Page 117: Parenteral fluid therapy

Prevention

• carefully insert needle

• use diligent care when a patient has a bleeding disorder,

takes anticoagulant medication, or has advanced liver

disease

Page 118: Parenteral fluid therapy

Clotting and Obstruction

• Blood clots may form in the IV line as a result of

• kinked IV tubing

• very slow infusion rate

• Empty IV bag

• failure to flush the IV line after intermittent medication or solution

administrations.

• The signs are decreased flow rate and blood backflow

into the IV tubing.

Page 119: Parenteral fluid therapy

Management

• If blood clots in the IV line

• DC infusion

• Restart another site with a new cannula and administration set.

• The tubing should not be irrigated or milked. Neither the infusion

rate nor the solution container should be raised, and the clot should

not be aspirated from the tubing

Page 120: Parenteral fluid therapy

Prevention

• Do not permit IV solution bag to run dry

• Tape the tubing to prevent kinking and maintain patency

• Maintain adequate flow rate

• Flushing line after intermittent medication or other solution

administration.

• In some cases, a specially trained nurse or physician

• may inject a thrombolytic agent into the catheter to clear

an occlusion resulting from fibrin or clotted blood.

Page 121: Parenteral fluid therapy

Local Complication-

Site Infection

• Site infection

• S & S

• Interventions

• Prevention

Page 122: Parenteral fluid therapy

Local complication-

Tissue Sloughing

• Tissue Sloughing

• S & S

• Interventions

• Prevention

Page 123: Parenteral fluid therapy
Page 124: Parenteral fluid therapy

Systemic Complication

• Circulatory or Fluid Overload

• Septicemia/ Systemic Infection

• Pulmonary Edema

• Catheter Embolism

• Air Embolism

• Pulmonary Embolus

Page 125: Parenteral fluid therapy

Fluid Overload

• Overloading the circulatory system with excessive IV

fluids causes increased blood pressure and central

venous pressure.

Page 126: Parenteral fluid therapy

Fluid Overload – S/S

• moist crackles on auscultation of the lungs

• Edema

• weight gain

• Dyspnea

• respirations : shallow and increased rate.

Page 127: Parenteral fluid therapy

Fluid Overload – causes

• rapid infusion of an IV solution or hepatic, cardiac, or

renal disease.

• risk for fluid overload and subsequent pulmonary edema

is especially increased in elderly patients with cardiac

• disease; this is referred to as circulatory overload.

Page 128: Parenteral fluid therapy

Management

• Decrease IV rate

• Monitor VS frequently

• Assess breath sounds

• Place patient in high Fowler’s position

• Contact physician immediately.

Page 129: Parenteral fluid therapy

Prevention

• Use infusion pump for infusions

• carefully monitoring all infusions.

• Complications of circulatory overload

• include heart failure and pulmonary edema.

Page 130: Parenteral fluid therapy

Air Embolism

• risk of air embolism is rare but ever-present.

• most often associated with cannulation of central veins.

Page 131: Parenteral fluid therapy

Air Embolism

• dyspnea

• Cyanosis

• hypotension

• weak, rapid pulse

• loss of consciousness

• chest, shoulder, and low back pain.

Page 132: Parenteral fluid therapy

Management

• Immediately clamp the cannula

• Place patient on the left side in Trendelenburg position,

• Assess VS and breath sounds

• Administer oxygen.

Page 133: Parenteral fluid therapy

Prevention

• Use a Luer-Lock adapter on all lines

• filling all tubing completely with solution

• Use an air detection alarm on an IV pump.

Page 134: Parenteral fluid therapy

Septicemia and Other Infection

• Pyrogenic substances in either the infusion solution or the

IV administration set can induce a febrile reaction and

septicemia.

Page 135: Parenteral fluid therapy

S/s

• abrupt temperature elevation shortly after the infusion is

started

• Backache

• Headache

• increased pulse and respiratory rate

• Nausea and vomiting

• Diarrhea

• chills and shaking

• general malaise.

• In severe septicemia:

• vascular collapse and septic shock

Page 136: Parenteral fluid therapy

Causes of septicemia

• contamination of the IV product or a break in aseptic

technique

• especially in immunocompromised patients.

Page 137: Parenteral fluid therapy

Management

• Treatment is symptomatic

• culturing of the IV cannula, tubing, or solution if suspect

• establishing a new IV site for medication or fluid

administration.

Page 138: Parenteral fluid therapy

• Infection ranges in severity from local involvement of the

insertion site to systemic dissemination of organisms

through the bloodstream, as in septicemia.

• Measures to prevent infection are essential at the time the

IV line is inserted and throughout the entire infusion.

Page 139: Parenteral fluid therapy

Prevention

• Careful hand hygiene before every contact with any part

of the infusion system or patient

• Examine the IV containers for cracks, leaks, or

cloudiness, which may indicate a contaminated solution

• Use strict aseptic technique

Page 140: Parenteral fluid therapy

Prevention

• Firmly anchor the IV cannula to prevent to-and-fro

motion

• Inspect the IV site daily and replace a soiled or wet

dressing with a dry sterile dressing. (Antimicrobial agents

that should be used for site care include 2% tincture of

iodine, 10% povidone–iodine, alcohol, or chlorhexidine,

used alone or in combination.

Page 141: Parenteral fluid therapy

Prevention

• Remove the IV cannula at the first sign of local

inflammation, contamination, or complication

• Replace the peripheral IV cannula every 48 to 72 hours,

or as indicated

• Replace the IV cannula inserted during emergency

conditions

(with questionable asepsis) as soon as possible

Page 142: Parenteral fluid therapy

Prevention

• Use a 0.2-micron air-eliminating and bacteria/particulate

retentive filter with non-lipid-containing solutions that

require filtration.

• The filter can be added to the proximal or distal end of the

administration set.

• If added to the proximal end between the fluid container and the

tubing spike, the filter ensures sterility and particulate removal from

the infusate container and prevents inadvertent infusion of air.

• If added to the distal end of the administration set, it filters air

particles and contaminants introduced from add-on devices,

secondary administration sets, or interruptions to the primary

system

Page 143: Parenteral fluid therapy

Disposable Infusion Set IV Filter

Page 144: Parenteral fluid therapy

Prevention

• Replace solution bag and administration set in

accordance with agency policy and procedure

• Infuse or discard medication or solution within 24 hours of

its addition to an administration set

• Change primary and secondary continuous administration

sets every 72 hours, or immediately if contamination is

suspected

• Change primary intermittent administration sets every 24

hours, or immediately if contamination is suspected

Page 145: Parenteral fluid therapy

References

• Brunner, L. S., Suddarth, D. S., & Smeltzer, S. C. O.

(2008). Brunner & Suddarth's textbook of medical-

surgical nursing (11th ed.). Philadelphia: Lippincott

Williams & Wilkins.

• http://webhome.broward.edu/~gbrickma/Slides/IV%20The

rapy%209-12-08.ppt

• http://www.mc.vanderbilt.edu/root/sbworddocs/proceed_n

ursing/Revised_web_IV_therapy.ppt

• http://uqu.edu.sa/files2/tiny_mce/plugins/filemanager/files/

4300164/Type%20and%20indication%20of%20IV%20ther

apy%202.ppt

• http://faculty.irsc.edu/FACULTY/SWise/IV%20therapy.PPT